NGL Fine-Chem Ltd (NSE:NGLFINE) Share Price

Company Profile

Business description
NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. It is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health, catering to various companies to custom-manufacture pharmaceuticals. The company's product portfolio comprises animal health APIs such as homidium chloride, nitroxynil, clorsulon, decoquinate, fenbendazole, etc.; human health APIs such as nitazoxanide and atovaquone; drug intermediates and specialty chemicals; and finished dosage forms such as diminazene aceturate granules and homidium chloride tablets. Geographically, the group generates maximum revenue from the Asia-Pacific region, and the rest from India, Europe, the USA, and the rest of the world.
Contact
301, E Square, Subhash Road
Vile Parle (East)
MumbaiMH400057
IND
T: +91 2240842222
https://www.nglfinechem.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 March 2027
Employees
523

Recommended

Sales growth but lack of margin expansion due to competition.

Johannes Faul, CFA | 15 June 2026

Discounted Aussie shares that offer a tax rebate.

Tyger Fitzpatrick | 14 June 2026

Pre-IPO holders could start selling later this summer, and earnings will be an important test.

Tom Lauricella | 14 June 2026

Index	Last price	Change	% Change
All Ordinaries	9,128.00	14.60	0.16%
CAC 40	8,451.12	100.25	1.20%
DAX 40	24,980.41	345.11	1.40%
Dow JONES (US)	51,202.26	353.51	0.70%
FTSE 100	10,474.61	2.89	0.03%
HKSE	24,842.67	124.57	0.50%
NASDAQ	25,888.84	79.18	0.31%
Nikkei 225	69,317.50	3,297.46	4.99%
NZX 50 Index	13,360.59	33.28	-0.25%
S&P 500	7,431.46	0.00	0.00%
S&P/ASX 200	8,914.00	7.00	0.08%
SSE Composite Index	4,096.47	64.96	1.61%